Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors

  title={Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors},
  author={A. Hurt and Hui-Ting Ho and I. Barr},
  journal={Expert Review of Anti-infective Therapy},
  pages={795 - 805}
  • A. Hurt, Hui-Ting Ho, I. Barr
  • Published 2006
  • Medicine
  • Expert Review of Anti-infective Therapy
  • Development of effective drugs for the treatment or prevention of epidemic and pandemic influenza is important in order to reduce its impact. Adamantanes and neuraminidase inhibitors are two classes of anti-influenza drugs available for influenza therapy currently. However, emergence of resistance to these drugs has been detected, which raises concerns regarding their widespread use. In this review, resistance to the adamantanes and neuraminidase inhibitors will be discussed in relation to both… CONTINUE READING

    Topics from this paper.

    Paper Mentions

    The aims of this study are to characterise the clinical efficacy and virological clearance dynamics of orally administered oseltamivir in patients with influenza caused by novel… Expand
    ConditionsInfluenza A Virus Infection
    Systematic review of influenza resistance to the neuraminidase inhibitors
    • 159
    • Highly Influenced
    • PDF
    Antivirals and resistance: influenza virus.
    • 131
    Neuraminidase inhibitor resistance in influenza viruses
    • 91
    In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
    • 102
    • PDF
    Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.
    • 91
    • PDF
    A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade
    • 34
    • PDF


    Publications referenced by this paper.
    Neuraminidase inhibitors for influenza.
    • 948
    • PDF
    Avian flu: Isolation of drug-resistant H5N1 virus
    • 677
    Antiviral Activity of 1-Adamantanamine (Amantadine)
    • 637